Development of a hydrophilic interaction liquid chromatography-tandem mass spectrometric method for the determination of kinsenoside, an antihyperlipidemic candidate, in rat plasma and its application to pharmacokinetic studies

J Pharm Biomed Anal. 2016 Feb 20:120:19-24. doi: 10.1016/j.jpba.2015.12.003. Epub 2015 Dec 4.

Abstract

Kinsenoside is a major bioactive constituent isolated from Anoectochilus formosanus and is investigated as an antihyperlipidemic candidate. In this study, a rapid, sensitive, and reliable bioanalytical method was developed for the determination of kinsenoside in rat plasma using hydrophilic interaction liquid chromatography-tandem mass spectrometry (HILIC-MS/MS). The plasma sample was pretreated with 1% acetic acid, followed by protein precipitation with acetonitrile:methanol (70:30). Chromatographic separation was performed on a HILIC silica column (2.1mm×100mm, 3μm). The mobile phases consisted of 0.1% acetic acid in distilled water (solvent A) and 0.1% acetic acid in acetonitrile (solvent B). A gradient program was used at a flow rate of 0.2mL/min. For mass spectrometric detection, the multiple reaction monitoring mode was used; the MRM transitions were m/z 265.2→m/z 102.9 for kinsenoside and m/z 163.3→m/z 132.1 for the internal standard (IS) nicotine in the positive ionization mode. A calibration curve was constructed in the range of 2-500ng/mL. The intra- and interday precision and accuracy were within 5%. The HILIC-MS/MS method was specific, accurate, and reproducible and was successfully applied in a pharmacokinetic study of kinsenoside in rats.

Keywords: Antihyperlipidemic agent; Kinsenoside; LC–MS/MS; Pharmacokinetics; Plasma.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 4-Butyrolactone / analogs & derivatives*
  • 4-Butyrolactone / blood
  • 4-Butyrolactone / pharmacokinetics
  • Animals
  • Calibration
  • Chromatography, Liquid / methods*
  • Hydrophobic and Hydrophilic Interactions
  • Hypolipidemic Agents / blood*
  • Hypolipidemic Agents / pharmacokinetics*
  • Monosaccharides / blood*
  • Monosaccharides / pharmacokinetics*
  • Plasma / chemistry*
  • Rats
  • Reproducibility of Results
  • Tandem Mass Spectrometry / methods*

Substances

  • 3-glucopyranosyloxybutanolide
  • Hypolipidemic Agents
  • Monosaccharides
  • 4-Butyrolactone